HSTM combines a consistent earnings-beat track record and excellent cash conversion with a rich valuation, elevated leverage, and a negative risk-reward asymmetry now that its price target has effectively been reached.
Thesis pillars
- Strong Earnings Beat Track Record→Stable
- Excellent Cash Conversion Quality→Stable
- Rich Valuation With Limited Upside→Stable
- +2 more pillars — see the Why tab for full reasoning
HealthStream, Inc. (HSTM) Stock Analysis
Breakout setup
Healthcare · Health Information Services
Hold if already holding. Not a fresh buy at $28.18, but acceptable to hold if already in. Reasons: Concentration risk — Customer: healthcare industry; Analyst target reached - limited upside remaining.
HealthStream provides SaaS-based workforce development solutions to U.S. healthcare organizations, spanning learning and compliance training, clinical competency development, staff scheduling, and credentialing/privileging through its hStream technology platform. The company,... Read more
Hold if already holding. Not a fresh buy at $28.18, but acceptable to hold if already in. Reasons: Concentration risk — Customer: healthcare industry; Analyst target reached - limited upside remaining. Chart setup: Golden cross, above all MAs, RSI 69, MACD bullish. Maintain position. Not compelling to add more. Score 5.8/10, moderate confidence.
Passes 6/8 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 27d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHCustomerhealthcare industry10-K Item 1A: 'our lack of market diversification resulting from our concentration on the healthcare industry may make us susceptible to losing market share to our competitors'
- MEDIUMCustomerhealthcare provider customers10-K Item 1: 'We derive a substantial portion of our revenues from a relatively small number of customers that are healthcare providers.'
Material Events(8-K, last 90d)
- 2026-05-08Item 5.02LOWMichael M. Collier was promoted to Chief Operating Officer and EVP from EVP, Corporate Strategy, Development & Operations, effective May 4, 2026, and granted options for 18,781 shares. Routine promotion, not a departure.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $28.18, but acceptable to hold if already in. Reasons: Concentration risk — Customer: healthcare industry; Analyst target reached - limited upside remaining. Chart setup: Golden cross, above all MAs, RSI 69, MACD bullish. Maintain position. Not compelling to add more. Target $29.40 (+4.3%), stop $26.21 (−7.5%), A.R:R -0.3:1. Score 5.8/10, moderate confidence.
Take-profit target: $29.40 (+4.3% upside). Target $29.40 (+4.3%), stop $26.21 (−7.5%), A.R:R -0.3:1. Stop-loss: $26.21.
Concentration risk — Customer: healthcare industry; Analyst target reached - limited upside remaining; Near 52-week high (4.9% away).
HealthStream, Inc. trades at a P/E of 43.4 (forward 33.6). TrendMatrix value score: 3.6/10. Verdict: Hold.
11 analysts cover HSTM with a consensus score of 4.0/5. Average price target: $32.
What does HealthStream, Inc. do?HealthStream provides SaaS-based workforce development solutions to U.S. healthcare organizations, spanning learning...
HealthStream provides SaaS-based workforce development solutions to U.S. healthcare organizations, spanning learning and compliance training, clinical competency development, staff scheduling, and credentialing/privileging through its hStream technology platform. The company, organized as a single reportable segment since 2023, derives a substantial portion of its subscription-based revenue from a relatively small number of healthcare-provider customers, though no single customer exceeded 10% of 2025 revenue, and has grown through acquisitions including Virsys12 and MissionCare Collective in 2